What physicians should know about FDA's new proposed guidance ...
Infectious diseases continue to pose significant challenges to public health systems worldwide, particularly in settings where resources, surveillance ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...